Bulletin from the annual general meeting in EQL Pharma AB on 20 August 2026
Regulatory
Today, on 20 August 2026, the annual general meeting was held in EQL Pharma AB. A summary of the adopted resolutions follows below.
Media
Here you can take part in regulatory and non-regulatory press releases and presentations.
Read More
Press Releases
Memprex© (methenamine hippurate) license signed with partner for Hungary
EQL's key product Memprex© has now been licensed for sale in Hungary with Pharmacenter, a leading local pharmaceutical company specialising in orphan drugs, oncology, urology and hospital products ...
Interim Report April - June 2026
Regulatory
EQL is going through a challenging period, with supply disruptions and technically more complex products in the launch phase, which has caused delays